Dorothy Shulman
Pediatric Endocrinology · Tampa, FLNPI 1700896636
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 84.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $26,770 and has fallen 70.8% since, to $7,817 in 2025. Among pediatric endocrinology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $644.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$88K
- Novo Nordisk$7K
- Biomarin Pharmaceutical Inc.$5K
- Pfizer$1K
- Tandem Diabetes Care, Inc.$936
- Ultragenyx Pharmaceutical Inc.$370
- plus $1K from 10 others
Across 333 payments — averaging $10,345 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$3.4M
- Ascendis Pharma Endocrinology Inc$25K
- Pfizer$7K
What the payments were for
- Consulting fees$48,12946%
- Speaking & faculty fees$41,10039%
- Travel & lodging$9,0979%
- Food & beverage$6,0356%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 117 | $88,451 |
| Novo Nordisk | 8 | $7,450 |
| Biomarin Pharmaceutical Inc. | 12 | $4,855 |
| Pfizer | 3 | $1,063 |
| Tandem Diabetes Care, Inc. | 4 | $936 |
| Ultragenyx Pharmaceutical Inc. | 4 | $370 |
| AstraZeneca | 2 | $237 |
| Kyowa Kirin, Inc. | 2 | $236 |
| Ascendis Pharma Endocrinology Inc | 2 | $155 |
| Neurocrine Biosciences, Inc. | 1 | $134 |
| AbbVie | 2 | $134 |
| Sanofi-aventis U.S. LLC | 1 | $124 |
| BETA Bionics, Inc. | 1 | $123 |
| Dexcom, Inc. | 1 | $84 |
| Mannkind Corporation | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 770G$12,770
- Sogroya$7,241
- MINIMED 780G$5,088
- Minimed 670G System$1,923
- t-slim insulin pump$791
- CRYSVITA$516
- GENOTROPIN$499
- Minimed 770G System$411
- iLet Bionic Pancreas$368
- CRENESSITY$134
- t:slim X2 Insulin Pump with Control-IQ$126
- Strensiq$125
- Lupron Depot$121
How this compares
$104,390 in reported general payments places this provider in the 95th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Tampa
- Henry RodriguezTampa$211K
- Danielle ReynoldsTampa$8K
- Terry DeclueTampa$6K
- Grace DouganTampa$6K
- Tsu-Hui LinTampa$3K
- Joshua YangOrlando$846K
- Michael HallerGainesville$102K
- Alejandro DiazMiami$101K
- Samuel FreedmanPembroke Pines$71K
- Jennifer MillerGainesville$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.